New combo shows promise for tough liver and bile duct cancers
NCT ID NCT03092895
First seen Feb 01, 2026 · Last updated May 13, 2026 · Updated 15 times
Summary
This study tested a new combination treatment for people with advanced liver cancer or bile duct cancer. It used an immunotherapy drug (SHR-1210) plus either a targeted therapy (apatinib) or chemotherapy. The goal was to see if the combination was safe and could shrink tumors. 157 patients took part, and the results help guide future treatment options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BILIARY TRACT CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
81 Hospital Nanjing
Nanjing, Jiangsu, 210002, China
-
Cancer Hospital of Henan province
Zhengzhou, Henan, 450008, China
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China
-
Hunan Cancer Hospital
Hunan, Changsha, 410000, China
-
The First Affiliated Hospital of Nanchang University
Jiangxi, Nanchang, 330006, China
-
The Second Affiliated Hospital Of Anhui Medical University
Hefei, Anhui, 230000, China
-
Zhongshan Hospital
Shanghai, Shanghai Municipality, 200003, China
Conditions
Explore the condition pages connected to this study.